An additional (so-called) benefit of this alternative brand of vaccine technology is that, once developed, it will not require refrigeration. Naturally, this has considerable implications for wide-spread use in third world countries. Unsurprisingly, funding for this emerging variation of vaccine technology is coming from the NIH as well as the Bill and Melinda Gates Foundation.
It goes without saying that pharmaceutical companies have become so infused into our globalized wellness infrastructure to the point that we don’t even see them anymore. They have become pervasively entrenched into the background of our social fabric, and are considered as mundanely-important and essential as the plumbing in our houses and our cities. This widespread habituation has ultimately numbed our sense of collective concern to the point where we aren’t as alarmed by how their products are conceived, nor by who is ultimately funding their research and development.